Correlation Between 23Andme Holding and XTL Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between 23Andme Holding Co and XTL Biopharmaceuticals Ltd, you can compare the effects of market volatilities on 23Andme Holding and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and XTL Biopharmaceutica.

Diversification Opportunities for 23Andme Holding and XTL Biopharmaceutica

0.73

Correlation Coefficient

23Andme Holding  XTL Biopharmaceutica

Poor diversification

The 3 months correlation between 23Andme and XTL is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and XTL Biopharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and XTL Biopharmaceutica go up and down completely randomly.

Pair Corralation between 23Andme Holding and XTL Biopharmaceutica

Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the XTL Biopharmaceutica. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.17 times less risky than XTL Biopharmaceutica. The stock trades about -0.15 of its potential returns per unit of risk. The XTL Biopharmaceuticals Ltd is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  240.00  in XTL Biopharmaceuticals Ltd on September 28, 2024 and sell it today you would lose (30.00) from holding XTL Biopharmaceuticals Ltd or give up 12.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

23Andme Holding Co  vs.  XTL Biopharmaceuticals Ltd

23Andme Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

XTL Biopharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days XTL Biopharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, XTL Biopharmaceutica is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with 23Andme Holding and XTL Biopharmaceutica

The main advantage of trading using opposite 23Andme Holding and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.

The idea behind 23Andme Holding Co and XTL Biopharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.